Advanced Search

 

Study ID Status Title Patient Level Data
117219 Completed Oral bioavailability study comparing OXEMET™ 1000 mg coated tablets containing metformin hydrochloride with 1000 mg of the reference product (GLAFORNIL™) administered as two 500 mg tablets, through a randomized, single-dose, open label, balanced, 2-way crossover study in healthy volunteers under fasting conditions.OXEMET (TM) is a trademark of the GlaxoSmithKline group of companies. GLAFORNIL(TM) is a trademark of Merck. Study Listed on ClinicalStudyDataRequest.com
117270 Completed A Randomised, Double-Blind (Sponsor-Unblind), Placebo Controlled, Cross-Over Study to Investigate the Efficacy, Effect on Cough Reflex Sensitivity, Safety, Tolerability and Pharmacokinetics of Inhaled GSK2339345 in Patients with Chronic Idiopathic Cough Using an Aqueous Droplet Inhaler Study Listed on ClinicalStudyDataRequest.com
117295 Completed Evaluation of use of belimumab in clinical practice settings
117300 Completed EVALUATION OF USE OF BELIMUMAB IN CLINICAL PRACTICE SETTINGS (OBSERVE): OBSERVATIONS FROM CANADA
117313 Completed A Single Center, Randomized, Open-Label, Sequential, Single Dose, 4-Period Crossover Study to Evaluate the Bioavailability and Food Effect of a Gelatin Formulation and Two Prototype Formulations of Afuresertib, an AKT Inhibitor, in Normal Healthy Volunteers
117326 Completed A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of 160 mg Enteric-coated Micronised Free Base Darapladib in Healthy Chinese Subjects. Study Listed on ClinicalStudyDataRequest.com
117342 Completed An Evaluation of the Bioequivalence of five 0.1 mg GI198745/dutasteride Soft Gelatin Capsules Compared to one 0.5 mg GI198745/dutasteride Gelatin Capsules in Healthy Male Volunteers Study Listed on ClinicalStudyDataRequest.com
200016 Completed An Open-Label Exploratory Study to Investigate the Feasibility of Administering Exenatide by Continuous Subcutaneous Infusion to Healthy Subjects
200065 Completed Glucagon-like peptide-1 (GLP-1) agonists: Treatment utilization patterns and risk of acute pancreatitis
200107 Completed An Open-label, Randomised, Single Dose, Three-Way Crossover, Six Sequence, Pilot Study to Determine the Relative Bioavailability of Montelukast Sodium 5mg from Two Candidate Chewable Tablet Formulations of GW483100 Relative to One 5mg Chewable Tablet of Reference Montelukast Sodium in Healthy Adult Subjects Under Fasting Conditions Study Listed on ClinicalStudyDataRequest.com
200109 Completed A study to compare the addition of umeclidinium bromide (UMEC) to fluticasone furoate (FF)/vilanterol (VI), with placebo plus FF/VI in subjects with Chronic Obstructive Pulmonary Disease (COPD) -Study 1 Study Listed on ClinicalStudyDataRequest.com
200110 Completed A study to compare the addition of umeclidinium bromide (UMEC) to fluticasone furoate (FF)/vilanterol (VI), with placebo plus FF/VI in subjects with Chronic Obstructive Pulmonary Disease (COPD) -Study 2 Study Listed on ClinicalStudyDataRequest.com
200142 Completed Study of barriers to adherence using the Adherence Starts with Knowledge 20 (ASK-20) in adult asthma patients receiving treatment with inhaled corticosteroid-containing drug products
200165 Completed Study 200165, A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Compare the Efficacy of a 2-Week Treatment with Fluticasone Propionate Nasal Spray versus Cetirizine in Adult Subjects with Seasonal Allergic Rhinitis (SAR) Study Listed on ClinicalStudyDataRequest.com
200167 Active, Not Recruiting Evidence synthesis to assess comparative efficacy of UMEC/VI versus other treatments for COPD adult patients
200173 Completed Renal Safety of Adefovir Dipivoxil (ADV) in Chinese Patients with Chronic Hepatitis B
200181 Completed A Randomized Double Blinded (Sponsor Unblind), Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Selective Androgen Receptor Modulator (SARM) in Single and Repeat Doses in Healthy Male Subjects
200185 Completed A Randomized, Double-blind (Sponsor Unblinded), Placebo Controlled, Repeat Dose Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin Study Listed on ClinicalStudyDataRequest.com
200195 Not yet recruiting Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Registry for Patients Treated with Strimvelis (or GSK2696273) Gene Therapy: Long-Term Prospective, Non-Interventional Follow-up of Safety and Effectiveness
200208 Terminated An open label, experimental medicine investigation of the safety and tolerability of 400 mg b.i.d. GSK2586184 in patients with moderate to severely active ulcerative colitis. Study Listed on ClinicalStudyDataRequest.com
200226 Completed Adjusting for treatment crossover in a Phase 2 trial of dabrafenib and trametinib combination therapy in patients with metastatic melanoma
200227 Active, Not Recruiting HO-13-9058 - Indirect treatment comparison (ITC) of mepolizumab versus omalizumab in the treatment of adults and adolescents (aged >=12 years) with severe asthma
200229 Completed An Open Label, Randomized, Two Part Study to Evaluate the CYP2C8- and OATP1B1-Mediated Drug-Drug Interaction Potential of GSK1278863 with Pioglitazone and Rosuvastatin as Victims and Trimethoprim as Perpetrator in Healthy Adult Volunteers Study Listed on ClinicalStudyDataRequest.com
200239 Completed Longitudinal Analysis of Efficacy and Safety of Alitretinoin in Patients with Severe Chronic Hand Eczema Refractory to Corticosteroids
200252 Completed A single-centre, randomized, open-label, 3-period crossover study using other inhalers as controls, non-pharmacological intervention, to investigate the operability of novel inhaler in subjects who have not previously used any of the inhalers assessed

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.